Smith & Nephew plc는 주당 0.78의 연간 배당금을 지급하며, 수익률은 0.00%입니다. 배당금은 반기별에 지급되며, 마지막 배당금 지급일은 Oct 3, 2025였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
0.00%
$0.78
Oct 3, 2025
지급 빈도
지급 비율
반기별
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
Oct 3, 2025
$0.30
Oct 3, 2025
Nov 7, 2025
Mar 28, 2025
$0.462
Mar 28, 2025
May 28, 2025
Oct 4, 2024
$0.288
Oct 4, 2024
Nov 8, 2024
Apr 1, 2024
$0.462
Apr 2, 2024
May 22, 2024
Oct 5, 2023
$0.288
Oct 6, 2023
Nov 1, 2023
Mar 30, 2023
$0.462
Mar 31, 2023
May 17, 2023
배당금 차트
SNN 배당금
SNN 배당금 성장률(년간 비교)
Follow-Up Questions
Smith & Nephew plc의 현재 배당금과 연간 배당금은 얼마인가요?
Smith & Nephew plc이 현재 지급하는 배당금은 $0.30입니다. Smith & Nephew plc의 연간 배당금은 $0.78입니다.
Smith & Nephew plc의 배당 성향은 얼마인가요?
Smith & Nephew plc의 배당 성향은 0.00%입니다.
SNN의 배당락일은 언제인가요?
Smith & Nephew plc의 배당락일은 Oct 3, 2025입니다.
Smith & Nephew plc은 얼마나 자주 배당금을 지급하나요?
분기별. Smith & Nephew plc이 마지막으로 배당금을 지급한 날짜는 Nov 7, 2025입니다.
주요 통계
이전 종가
$31.94
시가
$32.24
일일 범위
$32.06 - $32.44
52주 범위
$23.91 - $38.79
거래량
601.6K
평균 거래량
883.4K
배당수익률
--
EPS(TTM)
1.11
시가총액
$13.7B
Smith & Nephew SNATS, Inc.란 무엇인가요?
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.